New -Delhi: The Indian Council for Research on International Economic Relations (ICRIER) has requested that policy changes improve the access and affordability of vitamin D supplements and testing. In an Icrier report released on Tuesday, the import duty on vitamin D supplements and testing sets be reduced from 10% to 5%, which he believes will help reduce consumption costs and encourage early detection. It pointed out that targeted subsidies to promote domestic research and development of affordable test solutions and reformulated products. To improve affordability, the report recommended that the GST be reduced on vitamin D supplements. It also urged the government to regulate the prices of both plant and animal-based formulations of vitamin D. “Currently, only the formulation of Animal-based Source (NPPA) is under the purpose of the National Pharmaceutical Pricing Authority (NPPA), which creates a cost difference in a country where an estimated one of five individuals of vitamin D shortcoming emphasizes. Medicines as recommended by the World Health Organization. point of view warned that the long-term consequences of the widespread vitamin D deficiency-which ranges from bone disorders to weakened immunity-the Indian public health infrastructure and productivity. To strengthen the diagnostic capacity, the thinking tank also has a request for uniform test protocols in public and private health care institutions, which address existing contradictions in test quality and access. While government hospitals produce subsidized vitamin D tests at £ 200 to £ 500, private diagnostic laboratories charge significantly higher fees, which are often over £ 1,500. The recommendations of icrier come under pressure at a time when India’s spending on healthcare remains pressure, and preventative strategies such as nutritional interventions are seen as cost-effective tools to reduce long-term economic loss. Vitamin D is essential for bone health, and its deficit is related to severe skeletal disorders such as ragitis in children and osteomalacia in adults. “Insufficient levels can also lead to muscle weakness, fatigue and depression. In addition to bone health, vitamin D deficiency is related to an increased risk of cardiovascular disease, type 2 diabetes and cancers such as breast and prostate cancer,” dr. Aashish Chaudhry, a senior orthopedic surgeon and managing director, Aakash Healthcare. “Vitamin D deficiency is a silent epidemic that affects millions, but still overlooks it and places a significant economic burden on families and the healthcare system.
-
-
-
-
